Overview
Innovation in Biomaterials & Healthcare Technologies is a pioneering master's programme designed to equip you with the scientific, regulatory, and entrepreneurial expertise needed to transform cutting-edge research into real-world healthcare solutions. This course uniquely addresses the translational bottlenecks that often hinder the journey from laboratory innovation to patient care.
By integrating advanced biofabrication, New Approach Methodologies (NAMs), and the critical evaluation of AI, you will learn how to navigate the entire innovation pathway, from fundamental biomaterials science to global regulatory compliance and commercialisation.
Key benefits
- Integrate scientific, regulatory, biofabrication, and entrepreneurial expertise to navigate the regenerative medicine and healthcare technology landscape.
- Gain expertise in New Approach Methodologies (NAMs), medtech regulation, and AI to become a highly competitive graduate for emerging healthcare industries.
- Opportunity to conduct a research project that connects fundamental discovery with real-world biomedical and healthcare challenges, preparing you for careers in academia and industry.
- Learn from leading academics and benefit from industry-informed curricula in the heart of London
Course essentials
This new MSc is the first to combine cutting-edge science with the practical, regulatory, and business acumen needed to translate regenerative technologies into patient-ready solutions.
The course uniquely integrates critical translational and commercialisation pathways, preparing graduates to lead innovation in regenerative medicine. Students will gain:
-
Advanced Scientific Knowledge in biomaterials, tissue engineering, and regenerative technologies.
-
Regulatory & IP Expertise to navigate compliance and protect innovation.
-
Translational Pathway Skills for clinical adoption and stakeholder engagement.
-
Manufacturing & Scale-Up Strategies for cost-effective production.
-
Commercialisation Insights to align innovation with market success.
This programme is designed in alignment with strategic priorities identified by UKRMP, MHRA, NICE, BSI, and UK funding bodies, ensuring graduates are equipped to overcome the key bottlenecks in regenerative medicine and lead the next wave of innovation.
Administrative bodies
Regulating body
Application closing date guidance
This course will be open for applications in October 2026. Key application dates and deadlines will be available from October.
More details on this programme including modules and fees, will be available from October 2026.